Literature DB >> 30047071

Longitudinal changes in the quality of life of oral cancer patients during the perioperative period.

Takayuki Aoki1, Yoshihide Ota2, Takatsugu Suzuki2, Yuya Denda2, Ken-Ichi Aoyama2, Takeshi Akiba3, Mariko Naito4, Toshihiro Arai2.   

Abstract

BACKGROUND: There are few quality of life (QOL) studies that have focused on the experiences of oral cancer patients. Therefore, the present study aimed to investigate how the QOL for patients with oral cancer changed perioperatively.
METHODS: Eighty-three participants undergoing radical therapy completed assessments of QOL at pre-treatment, treatment completion, and 1-, 3-, and 6-months post-treatment. The Japanese version of the FACT-H&N, comprising the subscales of "physical well-being (PWB)," "social/family well-being (SWB)," "emotional well-being (EWB)," "functional well-being (FWB)," and "additional head- and neck-specific concerns(HN)" was used to assess QOL. There were two study groups: those who required reconstructive surgery (r+, 31 patients) and those who did not (r-, 52 patients).
RESULTS: The FACT-H&amp;N, PWB, FWB, and HN, were lowest at treatment completion due to declines; then, it showed significant improvement over time (p < 0.05). SWB was the highest at the completion of treatment, and thereafter decreased significantly until 3 months after treatment (p < 0.05). EWB was the lowest before treatment but improved over time (p < 0.01). HN was significantly lower at 6 months after treatment than before treatment (p < 0.05). The QOL of the r+ group was significantly lower than that of the r- group (p < 0.01).
CONCLUSIONS: The treatment-associated declines in subscale area may be compensated for by gains in other subscale areas. Psychological support is better introduced prior to cancer treatment. As it is often difficult to recover from declines in HN functioning subscale, strategies that promote compensation in other areas must be explored. Clinicians should become thoroughly familiar with how patients' QOL changes over time and provide holistic treatments that honor patients' autonomy.

Entities:  

Keywords:  Functional assessment of cancer therapy—head and neck; Oral cancer; Patient-reported outcomes; Perioperative period; Quality of life; Reconstructive surgery

Mesh:

Year:  2018        PMID: 30047071     DOI: 10.1007/s10147-018-1322-3

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  23 in total

1.  The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?

Authors:  R D Hays; J M Woolley
Journal:  Pharmacoeconomics       Date:  2000-11       Impact factor: 4.981

2.  A regulatory perspective on missing data in the aftermath of the NRC report.

Authors:  Lisa M LaVange; Thomas Permutt
Journal:  Stat Med       Date:  2015-12-17       Impact factor: 2.373

3.  The truly remarkable universality of half a standard deviation: confirmation through another look.

Authors:  Geoffrey R Norman; Jeff A Sloan; Kathleen W Wyrwich
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2004-10       Impact factor: 2.217

4.  A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).

Authors:  N I Cherny; R Sullivan; U Dafni; J M Kerst; A Sobrero; C Zielinski; E G E de Vries; M J Piccart
Journal:  Ann Oncol       Date:  2015-05-30       Impact factor: 32.976

5.  Changes in health-related quality of life of oral cancer patients treated with curative intent: experience of a developing country.

Authors:  J G Doss; W M N Ghani; I A Razak; Y H Yang; S N Rogers; R B Zain
Journal:  Int J Oral Maxillofac Surg       Date:  2017-03-16       Impact factor: 2.789

Review 6.  Methods for interpreting change over time in patient-reported outcome measures.

Authors:  K W Wyrwich; J M Norquist; W R Lenderking; S Acaster
Journal:  Qual Life Res       Date:  2012-04-17       Impact factor: 4.147

7.  Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer.

Authors:  Pernille Lassen; Hanne Primdahl; Jørgen Johansen; Claus A Kristensen; Elo Andersen; Lisbeth J Andersen; Jan F Evensen; Jesper G Eriksen; Jens Overgaard
Journal:  Radiother Oncol       Date:  2014-11-26       Impact factor: 6.280

8.  Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology.

Authors: 
Journal:  J Clin Oncol       Date:  1996-02       Impact factor: 44.544

Review 9.  New frontiers in patient-reported outcomes: adverse event reporting, comparative effectiveness, and quality assessment.

Authors:  Ethan Basch
Journal:  Annu Rev Med       Date:  2013-11-20       Impact factor: 13.739

Review 10.  A structured review and theme analysis of papers published on 'quality of life' in head and neck cancer: 2000-2005.

Authors:  S N Rogers; S A Ahad; A P Murphy
Journal:  Oral Oncol       Date:  2007-06-27       Impact factor: 5.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.